Drug
Epoetin Alfa-epbx
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Full Blood Count Abnormal | 21 | 19.1 | 19.3 | signal |
| 2 | Haemoglobin Decreased | 165 | 15.4 | 16.6 | signal |
| 3 | Dialysis | 21 | 14.2 | 14.3 | signal |
| 4 | Transfusion | 15 | 13.7 | 13.8 | signal |
| 5 | Haematocrit Decreased | 28 | 13.5 | 13.6 | signal |
| 6 | Full Blood Count Decreased | 26 | 12.4 | 12.5 | signal |
| 7 | Hospice Care | 12 | 11.7 | 11.8 | signal |
| 8 | Ischaemic Stroke | 20 | 10.7 | 10.8 | signal |
| 9 | Red Blood Cell Count Decreased | 30 | 10.1 | 10.2 | signal |
| 10 | Product Prescribing Error | 24 | 9.7 | 9.8 | signal |
| 11 | Blood Iron Decreased | 11 | 9.0 | 9.0 | signal |
| 12 | Syringe Issue | 14 | 7.7 | 7.7 | signal |
| 13 | Blood Count Abnormal | 12 | 7.5 | 7.5 | signal |
| 14 | Hypoacusis | 33 | 7.4 | 7.5 | signal |
| 15 | Nephropathy | 6 | 6.1 | 6.2 | signal |
| 16 | Myelodysplastic Syndrome | 9 | 6.0 | 6.0 | signal |
| 17 | Agranulocytosis | 11 | 5.7 | 5.7 | signal |
| 18 | Inappropriate Antidiuretic Hormone Secretion | 6 | 5.7 | 5.7 | signal |
| 19 | Bone Marrow Failure | 12 | 5.6 | 5.7 | signal |
| 20 | Breast Pain | 6 | 5.4 | 5.4 | signal |
| 21 | Anaemia | 105 | 5.3 | 5.5 | signal |
| 22 | Product Dispensing Error | 11 | 4.9 | 4.9 | signal |
| 23 | Blood Test Abnormal | 7 | 4.8 | 4.8 | signal |
| 24 | Glomerular Filtration Rate Decreased | 6 | 4.8 | 4.8 | signal |
| 25 | Needle Issue | 14 | 4.7 | 4.7 | signal |
| 26 | Death | 412 | 4.6 | 5.4 | signal |
| 27 | Immunodeficiency | 7 | 4.6 | 4.6 | signal |
| 28 | Device Mechanical Issue | 6 | 4.5 | 4.5 | signal |
| 29 | Hospitalisation | 70 | 4.4 | 4.5 | signal |
| 30 | Therapy Interrupted | 31 | 4.3 | 4.4 | signal |
| 31 | Quality Of Life Decreased | 6 | 4.3 | 4.3 | signal |
| 32 | Sickle Cell Anaemia With Crisis | 7 | 4.3 | 4.3 | signal |
| 33 | Drug Reaction With Eosinophilia And Systemic Symptoms | 11 | 4.1 | 4.1 | signal |
| 34 | Rash Maculo-papular | 9 | 3.9 | 3.9 | signal |
| 35 | Product Prescribing Issue | 8 | 3.8 | 3.8 | signal |
| 36 | Febrile Neutropenia | 26 | 3.8 | 3.8 | signal |
| 37 | Body Height Decreased | 4 | 3.6 | 3.6 | signal |
| 38 | Intentional Dose Omission | 10 | 3.5 | 3.5 | signal |
| 39 | Diarrhoea Haemorrhagic | 3 | 3.1 | 3.1 | no signal |
| 40 | Sopor | 4 | 2.9 | 2.9 | no signal |
| 41 | Toxic Skin Eruption | 3 | 2.8 | 2.9 | no signal |
| 42 | Poor Quality Product Administered | 3 | 2.8 | 2.8 | no signal |
| 43 | Product Packaging Quantity Issue | 3 | 2.6 | 2.6 | no signal |
| 44 | Prostatic Specific Antigen Increased | 3 | 2.1 | 2.1 | no signal |
| 45 | Device Issue | 16 | 1.8 | 1.8 | no signal |
| 46 | Circumstance Or Information Capable Of Leading To Medication Error | 6 | 1.7 | 1.7 | no signal |
| 47 | Gynaecomastia | 5 | 1.5 | 1.5 | no signal |
| 48 | Product Storage Error | 13 | 1.4 | 1.4 | no signal |
| 49 | Device Delivery System Issue | 3 | 1.1 | 1.1 | no signal |
| 50 | Wrong Technique In Device Usage Process | 3 | 0.6 | 0.6 | no signal |
| 51 | Drug Dose Omission By Device | 4 | 0.5 | 0.5 | no signal |